Momentus Inc SEC Filings

Momentus Inc. (MNTS) filed a prospectus supplement updating its at-the-market (ATM) program capacity. The company may offer and sell shares of Class A common stock with an aggregate offering price of up to $3,812,914.01 under General Instruction I.B.6 of Form S‑3, through A.G.P./Alliance Global Partners as sales agent or principal.

This update reflects the one‑third public float limit. The public float used for the cap was $38,990,626.56, calculated from 22,801,536 non‑affiliate shares at $1.71 per share, the highest closing price within the prior 60 days. The company has already sold $9,183,961.51 over the last 12 months under I.B.6; the new capacity does not include those prior sales. If the public float rises, the company may file another supplement to increase available ATM capacity, and the I.B.6 limit falls away once float exceeds $75.0 million. MNTS last traded at $1.33 on October 17, 2025.

Momentus Inc. (MNTS) filed Amendment No. 1 to its Form S-1, adding Rule 473(b) language for the registration statement to become automatically effective 20 days after filing. The company states this amendment does not modify any provision of the prospectus, and a preliminary prospectus is omitted.

Administrative details include an estimated total offering expense of $61,927, comprising an SEC registration fee of $1,927, legal fees of $15,000, accounting fees of $40,000, and miscellaneous costs of $5,000, all to be paid by the registrant.

The filing’s Part II recaps prior financing arrangements, warrant issuances, loan agreements, and convertible notes, and references related registration rights and ownership limitations, but does not change terms of the underlying prospectus.

Momentus Inc. (MNTS) entered a warrant inducement agreement that led a holder to exercise existing warrants for cash, providing approximately $7,000,000 in gross proceeds. The holder exercised (i) March warrants for 2,142,858 shares at $1.43 per share and (ii) July warrants for 2,836,880 shares at $1.41 per share. The March warrants’ exercise price was reduced from $2.00 to $1.43, matching the October 13, 2025 closing price.

In return, Momentus will issue new inducement warrants to purchase up to 7,469,607 shares at an exercise price of $1.43 per share, exercisable on or after the date of required stockholder approval under Nasdaq rules, and expiring five years after that approval date. The company plans to file a registration statement within 30 days of October 14, 2025 to register the resale of the inducement warrant shares. A beneficial ownership cap limits exercises to 4.99% (or, at the purchaser’s election, 9.99%).

Momentus will pay A.G.P. approximately $494,500 in fees and up to $35,000 for legal expenses, and expects to use net proceeds for general corporate purposes.

Momentus Inc. filed a prospectus supplement to update how much Class A common stock it may sell under an at-the-market (ATM) sales agreement with A.G.P./Alliance Global Partners. The company reports an aggregate market value of common stock held by non-affiliates of $9,229,204.68, based on 14,496,133 non-affiliate shares and a closing price of $1.91 on August 13, 2025. Momentus has sold $4,440,368.79 of stock under the Form S-3 limit in the prior 12 months and therefore has $4,788,835.89 of additional capacity to sell under General Instruction I.B.6 of Form S-3. The company notes the one-third public-float cap applies while public float remains below $75.0M. Its Nasdaq ticker is MNTS and the last reported sale price was $1.37 on October 10, 2025.

Momentus Inc. filed an 8-K reporting that on September 30, 2025 it entered into multiple agreements with Baker & McKenzie LLP. The filing lists a Pre-Funded Common Stock Purchase Warrant, a General Release and Settlement Agreement, a Securities Purchase Agreement, and a Registration Rights Agreement, each dated September 30, 2025. Together these exhibits indicate the company and Baker & McKenzie documented a securities issuance framework and a release/settlement between the parties. The filings are presented as exhibits; the 8-K does not disclose monetary amounts, share counts, or further financial terms in the excerpt provided.

Momentus Inc. (MNTS) filed a Form D claiming an exemption under Rule 506(b) for a private securities offering. The filing lists the issuer as Momentus Inc., a Delaware corporation with a San Jose, California principal place of business at 3901 N. First Street. The Form D reports a total offering amount of $1,630,435, with $1,630,435 sold and . The offering included equity and options, warrants or other rights to acquire securities. The filing indicates one investor has already invested. The issuer identifies multiple related persons (executive officers and directors) including Jon Layman who signed as Chief Legal Officer and Corporate Secretary on 2025-10-02. The Form D states the offering is not in connection with a business combination and that the issuer selected an issuer size range of $1,000,001–$5,000,000 for aggregate net asset value.

Momentus Inc. entered into a sales agreement with A.G.P./Alliance Global Partners to sell, at its option, up to $7,350,000 of Class A common stock through an at-the-market program. The shares may be sold from time to time under the companys effective Form S-3 registration statement (File No. 333-290425) and the related prospectus supplement. The filing notes that legal opinion and consent from Bradley Arant Boult Cummings LLP are furnished as exhibits. The report clarifies it is not an offer in any jurisdiction where unlawful.

Momentus Inc. entered into a Sales Agreement with A.G.P./Alliance Global Partners on September 19, 2025, enabling the company to sell, at its option, up to $7,350,000 of Class A common stock through the Agent as an at-the-market offering or in negotiated transactions.

The sales may occur only upon effectiveness of a Form S-3 Registration Statement filed on September 22, 2025, which covers up to $50,000,000 of various securities. The Agent will use commercially reasonable efforts to sell shares per the company’s instructions and will receive a 3.0% commission on gross proceeds. The Company states it cannot assure any shares will be sold under the agreement. The Sales Agreement is attached as Exhibit 1.1 to the filing.